Concepedia

Xingxing Yuan

XY

Statistics

Publications

2

Citations

52

H-Index

2

Active since

2018

Affiliations

Fudan University Shanghai Cancer Center(Current)

Fudan University

Xingxing Yuan is an author at Fudan University Shanghai Cancer Center specializing in programmed death-ligand 1 inhibitors, cancer immunotherapy, and oncology.

ORCID

Publications per year

2018–2020

2

Publications

2

Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors

Xingxing Yuan, Zujun Sun, Qingyun Yuan et al. · Investigational New Drugs · 2020 · 31 citations

, , +14

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

Weihua Hou, Qingyun Yuan, Xingxing Yuan et al. · Investigational New Drugs · 2018 · 21 citations

, , +17

1–2 of 2